A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy Participants

Clinical trial NCT07198087 · COMPLETED

Trial details

NCT number: NCT07198087
Sponsor: Ono Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Central Nervous System Lymphoma (PCNSL)

Start date: 2025-10-01
Primary completion: 2026-04-09
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.